We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

Back to rankings

1 hedge funds and large institutions have $112M invested in NxStage Medical Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 171 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% less funds holding in top 10

Funds holding in top 10: 11 → 1 (-10)

93% less capital invested

Capital invested by funds: $1.73B → $112M (-$1.62B)

99% less funds holding

Funds holding: 172 → 1 (-171)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 171

Holders
1
Holders Change
-171
Holders Change %
-99.42%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-90.91%
% of All Funds
0.02%
New
–
Increased
–
Reduced
–
Closed
171
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$176M
2
BlackRock
BlackRock
New York
-$155M
3
AA
AQR Arbitrage
Connecticut
-$105M
4
MF
Magnetar Financial
Illinois
-$84.9M
5
AAM
Alpine Associates Management
Florida
-$69.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
XK
126
Xact Kapitalforvaltning
Sweden
– -$389K -13,595 Closed
Two Sigma Investments
127
Two Sigma Investments
New York
– -$338K -11,796 Closed
Parallax Volatility Advisers
128
Parallax Volatility Advisers
California
– -$315K -11,000 Closed
USAA
129
United Services Automobile Association
Texas
– -$291K -10,176 Closed
LCM
130
Landscape Capital Management
New Jersey
– -$287K -10,018 Closed
ACPU
131
Arrowgrass Capital Partners (US)
Delaware
– -$286K -10,000 Closed
Principal Financial Group
132
Principal Financial Group
Iowa
– -$286K -9,982 Closed
DAM
133
DLD Asset Management
New York
– -$277K -9,672 Closed
Jane Street
134
Jane Street
New York
– -$275K -9,610 Closed
AB
135
Amalgamated Bank
New York
– -$273K -9,529 Closed
RG
136
Rathbones Group
United Kingdom
– -$266K -9,300 Closed
JMPWA
137
JP Morgan Private Wealth Advisors
California
– -$260K -9,098 Closed
Public Employees Retirement Association of Colorado
138
Public Employees Retirement Association of Colorado
Colorado
– -$247K -8,635 Closed
PC
139
Paulson & Co
New York
– -$238K -8,300 Closed
Canada Life
140
Canada Life
Manitoba, Canada
– -$227K -8,228 Closed
MC
141
Menta Capital
California
– -$216K -7,545 Closed
TMAM
142
Tokio Marine Asset Management
Japan
– -$215K -7,500 Closed
Prudential Financial
143
Prudential Financial
New Jersey
– -$210K -7,326 Closed
Janus Henderson Group
144
Janus Henderson Group
United Kingdom
– -$209K -7,320 Closed
DIM
145
DC Investments Management
Virginia
– -$209K -7,286 Closed
PP
146
Paloma Partners
Connecticut
– -$200K -7,007 Closed
AIP
147
Ameritas Investment Partners
Nebraska
– -$157K -5,498 Closed
Zurich Cantonal Bank
148
Zurich Cantonal Bank
Switzerland
– -$126K -4,395 Closed
QT
149
Quantamental Technologies
New York
– -$110K -3,843 Closed
Simplex Trading
150
Simplex Trading
Illinois
– -$98K -3,435 Closed
3 4 5
6
7

NXTM Hedge Fund Activity: Q1 2019 in Review

1 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2019, worth a combined $112M — down 93% from $1.73B a quarter earlier.

Sellers outnumbered buyers: 171 funds closed out of NXTM and 0 opened new positions — a net loss of 171 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $176M sold.

  • 1 institutional investor held NxStage Medical Inc. (NXTM) as of Q1 2019, down from 172 in Q4 2018.
  • Funds reported $112M of NxStage Medical Inc. stock for Q1 2019, down 93% quarter-over-quarter.
  • 0 funds opened new NxStage Medical Inc. positions in Q1 2019 and 171 closed out, a net change of -171 holders.
  • The largest NxStage Medical Inc. seller in Q1 2019 was Vanguard Group, an estimated $176M sold.

Based on aggregated 13F filings for Q1 2019.